Works matching AU Mita, Alain

Results: 55

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study.

Published in:

2017

By:

Sarantopoulos, John;
Mita, Alain;
He, Aiwu;
Wade, James;
Hsueh, Chung-Tsen;
Morris, John;
Lockhart, A.;
Quinn, David;
Hwang, Jimmy;
Mier, James;
Zhang, Wenping;
Wack, Claudine;
Yin, Jian;
Clot, Pierre-François;
Rixe, Olivier;
Mita, Alain C;
Wade, James L;
Morris, John C;
Lockhart, A Craig;
Quinn, David I

Publication type:

journal article

Clinical activity of mammalian target of rapamycin inhibitors in solid tumors.

Published in:

2011

By:

Alvarado, Yesid;
Mita, Monica;
Vemulapalli, Sushma;
Mahalingam, Devalingam;
Mita, Alain;
Mita, Monica M;
Mita, Alain C

Publication type:

journal article

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.

Published in:

Oncology, 2019, v. 97, n. 2, p. 102, doi. 10.1159/000500571

By:

Hong, David;
Rasco, Drew;
Veeder, Michael;
Luke, Jason J.;
Chandler, Jason;
Balmanoukian, Ani;
George, Thomas J.;
Munster, Pamela;
Berlin, Jordan D.;
Gutierrez, Martin;
Mita, Alain;
Wakelee, Heather;
Samakoglu, Selda;
Guan, Shanhong;
Dimery, Isaiah;
Graef, Thorsten;
Borazanci, Erkut

Publication type:

Article

Bromodomain inhibitors a decade later: a promise unfulfilled?

Published in:

2020

By:

Mita, Monica M.;
Mita, Alain C.

Publication type:

Editorial

Bromodomain inhibitors a decade later: a promise unfulfilled?

Published in:

2020

By:

Mita, Monica M.;
Mita, Alain C.

Publication type:

Editorial

Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.

Published in:

2017

By:

Mita, Monica M;
Mita, Alain C;
Moseley, Jennifer L;
Poon, Jennifer;
Small, Karen A;
Jou, Ying-Ming;
Kirschmeier, Paul;
Zhang, Da;
Zhu, Yali;
Statkevich, Paul;
Sankhala, Kamelesh K;
Sarantopoulos, John;
Cleary, James M;
Chirieac, Lucian R;
Rodig, Scott J;
Bannerji, Rajat;
Shapiro, Geoffrey I

Publication type:

journal article

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.

Published in:

PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221994

By:

Wolin, Edward;
Mita, Alain;
Mahipal, Amit;
Meyer, Tim;
Bendell, Johanna;
Nemunaitis, John;
Munster, Pam N.;
Paz-Ares, Luis;
Filvaroff, Ellen H.;
Li, Shaoyi;
Hege, Kristen;
de Haan, Hans;
Mita, Monica

Publication type:

Article

Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1113, doi. 10.1007/s00280-014-2572-z

By:

Sarantopoulos, John;
Mita, Alain;
Wade, James;
Morris, John;
Rixe, Olivier;
Mita, Monica;
Dedieu, Jean-François;
Wack, Claudine;
Kassalow, Laurent;
Craig Lockhart, A.

Publication type:

Article

Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1241, doi. 10.1007/s00280-014-2602-x

By:

Mahalingam, Devalingam;
Nemunaitis, John;
Malik, Laeeq;
Sarantopoulos, John;
Weitman, Steven;
Sankhala, Kamalesh;
Hart, Jessica;
Kousba, Ahmed;
Gallegos, Nicole;
Anderson, Gavin;
Charles, John;
Rogers, Jon;
Senzer, Neil;
Mita, Alain

Publication type:

Article

Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 77, doi. 10.1007/s00280-014-2479-8

By:

Mahalingam, Devalingam;
Malik, Laeeq;
Beeram, Muralidhar;
Rodon, Jordi;
Sankhala, Kamalesh;
Mita, Alain;
Benjamin, Daniel;
Ketchum, Norma;
Michalek, Joel;
Tolcher, Anthony;
Wright, John;
Sarantopoulos, John

Publication type:

Article

Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors.

Published in:

2013

By:

Chen, Nianhang;
Chawla, Sant;
Chiorean, Elena;
Read, William;
Gorbaty, Mayer;
Mita, Alain;
Yung, Lotus;
Bryan, Peter;
McNally, Richard;
Renschler, Markus;
Sharma, Sunil

Publication type:

Report

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 35, doi. 10.1007/s00280-012-1963-2

By:

Nemunaitis, John;
Mita, Alain;
Stephenson, Joe;
Mita, Monica;
Sarantopoulos, John;
Padmanabhan-Iyer, Swami;
Nanda, Nisha;
Gleich, Lyon;
Benichou, Annie-Claude;
Craig, Adam

Publication type:

Article

A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 4, p. 751, doi. 10.1007/s00280-010-1372-3

By:

Tolcher, Anthony;
Appleman, Leonard;
Shapiro, Geoffrey;
Mita, Alain;
Cihon, Frank;
Mazzu, Arthur;
Sundaresan, Pavur

Publication type:

Article

Phase I study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 287, doi. 10.1007/s00280-008-0869-5

By:

Mita, Monica;
Mita, Alain;
Sarantopoulos, John;
Takimoto, Chris H.;
Rowinsky, Eric K.;
Romero, Ofelia;
Angiuli, Patrizia;
Allievi, Cecilia;
Eisenfeld, Amy;
Verschraegen, Claire F.

Publication type:

Article

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x

By:

Chia-Chi Lin;
Calvo, Emiliano;
Papadopoulos, Kyriakos P.;
Patnaik, Amita;
Sarantopoulos, John;
Mita, Alain C.;
Preston, Glenn G.;
Mita, Monica M.;
Rodon, Jordi;
Mays, Theresa;
I.-Tien Yeh;
O'Rourke, Pat;
Takimoto, Chris H.;
Dancey, Janet E.;
Chen, Helen;
Tolcher, Anthony W.

Publication type:

Article

A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 165, doi. 10.1007/s00280-006-0255-0

By:

Mita, Monica M.;
Rowinsky, Eric K.;
Forero, Leonardo;
Eckhart, S. Gail;
Izbicka, Elzbieta;
Weiss, Geoffrey R.;
Beeram, Muralidhar;
Mita, Alain C.;
de Bono, Johann S.;
Tolcher, Anthony W.;
Hammond, Lisa A.;
Simmons, Paul;
Berg, Kristin;
Takimoto, Chris;
Patnaik, Amita

Publication type:

Article

FGFR-Altered Urothelial Carcinoma: Resistance Mechanisms and Therapeutic Strategies: FGFR-Altered Urothelial Carcinoma: D. J. Benjamin, A. C. Mita.

Published in:

Targeted Oncology, 2025, v. 20, n. 1, p. 1, doi. 10.1007/s11523-024-01119-z

By:

Benjamin, David J.;
Mita, Alain C.

Publication type:

Article

A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.

Published in:

Targeted Oncology, 2023, v. 18, n. 4, p. 517, doi. 10.1007/s11523-023-00965-7

By:

Bauer, Todd M.;
Moore, Kathleen N.;
Rader, Janet S.;
Simpkins, Fiona;
Mita, Alain C.;
Beck, J. Thaddeus;
Hart, Lowell;
Chu, Quincy;
Oza, Amit;
Tinker, Anna V.;
Imedio, Esteban Rodrigo;
Kumar, Sanjeev;
Mugundu, Ganesh;
Jenkins, Suzanne;
Chmielecki, Juliann;
Jones, Suzanne;
Spigel, David;
Fu, Siqing

Publication type:

Article

Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer.

Published in:

2020

By:

Vail, Eric;
Song, Jianbo;
Xu, Jing;
Frye, Joseph S.;
Kim, Jong Taek;
Pao, Andy;
Schreck, Rhona;
Aguiluz, Angela S.;
Zhang, Wenjuan;
Alkan, Serhan;
Mita, Alain;
Mita, Monica;
Figlin, Robert A.;
Engman, David M.;
Lopategui, Jean R.

Publication type:

journal article

Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics.

Published in:

2017

By:

Tabatabai, Roya;
Linhares, Yuliya;
Bolos, David;
Mita, Monica;
Mita, Alain

Publication type:

journal article

Are we ready to move away from nature?: the rapamycin story.

Published in:

2011

By:

Mita, Monica;
Mita, Alain

Publication type:

journal article

The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas.

Published in:

2011

By:

Vemulapalli, Sushma;
Mita, Alain;
Alvarado, Yesid;
Sankhala, Kamalesh;
Mita, Monica

Publication type:

journal article

The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents.

Published in:

2009

By:

Sankhala, Kamalesh;
Mita, Alain;
Kelly, Kevin;
Mahalingam, Devalingam;
Giles, Francis;
Mita, Monica

Publication type:

journal article

Apoptosis: mechanisms and implications for cancer therapeutics.

Published in:

Targeted Oncology, 2006, v. 1, n. 4, p. 197, doi. 10.1007/s11523-006-0034-1

By:

Mita, Monica;
Mita, Alain;
Tolcher, Anthony

Publication type:

Article

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.

Published in:

Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 10, p. 2448, doi. 10.1111/j.1582-4934.2009.00832.x

By:

Carew, Jennifer S.;
Medina, Ernest C.;
Esquivel II, Juan A.;
Mahalingam, Devalingam;
Swords, Ronan;
Kelly, Kevin;
Zhang, Hui;
Huang, Peng;
Mita, Alain C.;
Mita, Monica M.;
Giles, Francis J.;
Nawrocki, Steffan T.

Publication type:

Article

Quantitative Nodal Burden and Mortality Across Solid Cancers.

Published in:

2022

By:

Nguyen, Anthony T;
Luu, Michael;
Nguyen, Vina P;
Lu, Diana J;
Shiao, Stephen L;
Kamrava, Mitchell;
Atkins, Katelyn M;
Mita, Alain C;
Scher, Kevin S;
Spratt, Daniel E;
Faries, Mark B;
Daskivich, Timothy J;
Lin, De-Chen;
Chen, Michelle M;
Clair, Jon Mallen-St;
Sandler, Howard M;
Ho, Allen S;
Zumsteg, Zachary S

Publication type:

journal article

Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer.

Published in:

Clinical Breast Cancer, 2014, v. 14, n. 3, p. 169, doi. 10.1016/j.clbc.2013.10.016

By:

Mita, Monica M.;
Joy, Anil A.;
Mita, Alain;
Sankha, Kamalesh;
Ying-Ming Jou;
Da Zhang;
Statkevich, Paul;
Yali Zhu;
Siu-Long Yao;
Small, Karen;
Bannerji, Rajat;
Shapiro, Charles L.

Publication type:

Article

Physiologically‐based pharmacokinetic modelling to predict oprozomib CYP3A drug–drug interaction potential in patients with advanced malignancies.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 3, p. 530, doi. 10.1111/bcp.13817

By:

Ou, Ying;
Xu, Yang;
Gore, Lia;
Harvey, R. Donald;
Mita, Alain;
Papadopoulos, Kyriakos P.;
Wang, Zhengping;
Cutler, Richard E.;
Pinchasik, Dawn E.;
Tsimberidou, Apostolia M.

Publication type:

Article

Baseline weight recovery and mortality risk in head and neck cancer.

Published in:

Head & Neck, 2025, v. 47, n. 1, p. 139, doi. 10.1002/hed.27898

By:

Bastien, Amanda J.;
Amin, Luv;
Vasquez, Missael;
Cong, Iris;
Luu, Michael;
Laszlo, Meghan;
Yen, Saori;
Thompson, Heather;
Teitelbaum, Elana L.;
Jang, Julie K.;
Mita, Alain C.;
Scher, Kevin S.;
Moyers, Justin;
Mallen‐St. Clair, Jon;
Walgama, Evan S.;
Zumsteg, Zachary S.;
Ho, Allen S.

Publication type:

Article

Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging system.

Published in:

Head & Neck, 2023, v. 45, n. 8, p. 2028, doi. 10.1002/hed.27429

By:

Ho, Allen S.;
Luu, Michael;
Balzer, Bonnie L.;
Aro, Katri;
Jang, Julie K.;
Mita, Alain C.;
Scher, Kevin S.;
Mallen‐St. Clair, Jon;
Vasquez, Missael;
Bastien, Amanda J.;
Epstein, Joel B.;
Lin, De‐Chen;
Chen, Michelle M.;
Zumsteg, Zachary S.

Publication type:

Article

Variations in the association of grade with survival across the head and neck cancer landscape.

Published in:

Head & Neck, 2021, v. 43, n. 4, p. 1105, doi. 10.1002/hed.26566

By:

Anderson, Eric M.;
Luu, Michael;
Balzer, Bonnie L.;
Scher, Kevin S.;
Mita, Alain C.;
Lu, Diana J.;
Shiao, Stephen L.;
Clair, Jon Mallen‐St.;
Ho, Allen S.;
Zumsteg, Zachary S.

Publication type:

Article

Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.

Published in:

Head & Neck, 2018, v. 40, n. 6, p. 1228, doi. 10.1002/hed.25100

By:

Yoshida, Emi J.;
Luu, Michael;
David, John M.;
Kim, Sungjin;
Mita, Alain;
Scher, Kevin;
Shiao, Stephen L.;
Tighiouart, Mourad;
Ho, Allen S.;
Zumsteg, Zachary S.

Publication type:

Article

Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.

Published in:

Investigational New Drugs, 2023, v. 41, n. 2, p. 284, doi. 10.1007/s10637-023-01342-x

By:

Jimeno, Antonio;
Baranda, Joaquina;
Iams, Wade T.;
Park, Jong Chul;
Mita, Monica;
Gordon, Michael S.;
Taylor, Matthew;
Dhani, Neesha;
Leal, Alexis D.;
Neupane, Prakash;
Eng, Cathy;
Yeku, Oladapo;
Mita, Alain;
Moser, Justin C.;
Butler, Marcus;
Loughhead, Scott M.;
Jennings, Julia;
Miselis, Nathan R.;
Ji, Rui-Ru;
Nair, Nitya

Publication type:

Article

Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.

Published in:

Investigational New Drugs, 2019, v. 37, n. 1, p. 76, doi. 10.1007/s10637-018-0602-0

By:

Sankhala, Kamalesh;
Takimoto, Chris H.;
Mita, Alain C.;
Xiong, Henry;
Rodón, Jordi;
Mehrvarz Sarshekeh, Amir;
Burns, K.;
Iizuka, Kenzo;
Kopetz, Scott

Publication type:

Article

Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2017, v. 35, n. 5, p. 616, doi. 10.1007/s10637-017-0442-3

By:

Mita, Monica;
Fu, Siqing;
Piha-Paul, Sarina;
Janku, Filip;
Mita, Alain;
Natale, Ronald;
Guo, Wei;
Zhao, Charles;
Kurzrock, Razelle;
Naing, Aung

Publication type:

Article

Pharmacokinetic study of aldoxorubicin in patients with solid tumors.

Published in:

Investigational New Drugs, 2015, v. 33, n. 2, p. 341, doi. 10.1007/s10637-014-0183-5

By:

Mita, Monica;
Natale, Ronald;
Wolin, Edward;
Laabs, Brenda;
Dinh, Hillary;
Wieland, Scott;
Levitt, Daniel;
Mita, Alain

Publication type:

Article

Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2014, v. 32, n. 6, p. 1236, doi. 10.1007/s10637-014-0145-y

By:

Lockhart, A.;
Sundaram, Shankar;
Sarantopoulos, John;
Mita, Monica;
Wang-Gillam, Andrea;
Moseley, Jennifer;
Barber, Stephanie;
Lane, Alex;
Wack, Claudine;
Kassalow, Laurent;
Dedieu, Jean-François;
Mita, Alain

Publication type:

Article

Metabolism of patupilone in patients with advanced solid tumor malignancies.

Published in:

Investigational New Drugs, 2013, v. 31, n. 3, p. 605, doi. 10.1007/s10637-012-9838-2

By:

Kelly, Kevin;
Zollinger, Markus;
Lozac'h, Frédéric;
Tan, Eugene;
Mita, Alain;
Waldmeier, Felix;
Urban, Patrick;
Anand, Suraj;
Wang, Yanfeng;
Swart, Piet;
Takimoto, Chris;
Mita, Monica

Publication type:

Article

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel.

Published in:

Investigational New Drugs, 2012, v. 30, n. 3, p. 1065, doi. 10.1007/s10637-011-9642-4

By:

Millward, Michael;
Mainwaring, Paul;
Mita, Alain;
Federico, Kristine;
Lloyd, G.;
Reddinger, Natasha;
Nawrocki, Steffan;
Mita, Monica;
Spear, Matthew

Publication type:

Article

Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2014, v. 63, n. 8, p. 787, doi. 10.1007/s00262-014-1547-6

By:

Smith, David;
Conkling, Paul;
Richards, Donald;
Nemunaitis, John;
Boyd, Thomas;
Mita, Alain;
Bourdonnaye, Guillaume;
Wages, David;
Bexon, Alice

Publication type:

Article

Case Report of CCDC149–ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma.

Published in:

Thyroid, 2022, v. 32, n. 12, p. 1580, doi. 10.1089/thy.2022.0389

By:

Lee, Hannah;
Krishnan, Vimal;
Wirth, Lori J.;
Nucera, Carmelo;
Venturina, Mariza;
Sadow, Peter M.;
Mita, Alain;
Sacks, Wendy

Publication type:

Article

Phase 1 dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 3177, doi. 10.2147/OTT.S128547

By:

Yao, James C.;
Chan, Jennifer A.;
Mita, Alain C.;
Kundu, Madan G.;
Reséndiz, Karina Hermosillo;
Ke Hu;
Ravichandran, Shoba;
Strosberg, Jonathan R.;
Wolin, Edward M.

Publication type:

Article

Combined autophagy and HDAC inhibition.

Published in:

Autophagy, 2014, v. 10, n. 8, p. 1403, doi. 10.4161/auto.29231

By:

Mahalingam, Devalingam;
Mita, Monica;
Sarantopoulos, John;
Wood, Leslie;
Amaravadi, Ravi K.;
Davis, Lisa E.;
Mita, Alain C.;
Curiel, Tyler J.;
Espitia, Claudia M.;
Nawrocki, Steffan T.;
Giles, Francis J.;
Carew, Jennifer S.

Publication type:

Article

Nodal staging convergence for HPV− and HPV+ oropharyngeal carcinoma.

Published in:

Cancer (0008543X), 2021, v. 127, n. 10, p. 1590, doi. 10.1002/cncr.33414

By:

Ho, Allen S.;
Luu, Michael;
Kim, Sungjin;
Tighiouart, Mourad;
Mita, Alain C.;
Scher, Kevin S.;
Mallen‐St. Clair, Jon;
Walgama, Evan S.;
Lin, De‐Chen;
Nguyen, Anthony T.;
Zumsteg, Zachary S.

Publication type:

Article

Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?

Published in:

2020

By:

Yoshida, Emi J.;
Luu, Michael;
Mallen‐St. Clair, Jon;
Mita, Alain C.;
Scher, Kevin S.;
Lu, Diana J.;
Nguyen, Anthony T.;
Shiao, Stephen L.;
Ho, Allen S.;
Zumsteg, Zachary S.;
Mallen-St Clair, Jon

Publication type:

journal article

Quantitative survival impact of composite treatment delays in head and neck cancer.

Published in:

2018

By:

Ho, Allen S.;
Kim, Sungjin;
Tighiouart, Mourad;
Mita, Alain;
Scher, Kevin S.;
Epstein, Joel B.;
Laury, Anna;
Prasad, Ravi;
Ali, Nabilah;
Patio, Chrysanta;
Clair, Jon Mallen‐St.;
Zumsteg, Zachary S.;
Clair, Jon Mallen-St

Publication type:

journal article

Combined high-intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base.

Published in:

2017

By:

Zumsteg, Zachary S.;
Luu, Michael;
Yoshida, Emi J.;
Kim, Sungjin;
Tighiouart, Mourad;
David, John M.;
Shiao, Stephen L.;
Mita, Alain C.;
Scher, Kevin S.;
Sherman, Eric J.;
Lee, Nancy Y.;
Ho, Allen S.

Publication type:

journal article

Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.

Published in:

2017

By:

David, John M.;
Ho, Allen S.;
Luu, Michael;
Yoshida, Emi J.;
Kim, Sungjin;
Mita, Alain C.;
Scher, Kevin S.;
Shiao, Stephen L.;
Tighiouart, Mourad;
Zumsteg, Zachary S.

Publication type:

journal article

Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.

Published in:

2017

By:

Zumsteg, Zachary S.;
Kim, Sungjin;
David, John M.;
Yoshida, Emi J.;
Tighiouart, Mourad;
Shiao, Stephen L.;
Scher, Kevin;
Mita, Alain;
Sherman, Eric J.;
Lee, Nancy Y.;
Ho, Allen S.

Publication type:

journal article

Impact of insurance on survival in patients < 65 with head & neck cancer treated with radiotherapy.

Published in:

Clinical Otolaryngology, 2020, v. 45, n. 1, p. 63, doi. 10.1111/coa.13467

By:

Sittig, Mark P.;
Luu, Michael;
Yoshida, Emi J.;
Scher, Kevin;
Mita, Alain;
Shiao, Stephen L.;
Lu, Diana J.;
Mallen‐St. Clair, Jon;
Ho, Allen S.;
Zumsteg, Zachary S.

Publication type:

Article